Cold-induced sweating syndrome

disease
On this page

Also known as CISS

Summary

Cold-induced sweating syndrome (MONDO:0015526) is a disease with 3 cohort genes.

At a glance

  • Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
  • Cohort genes: 3
  • ClinVar variants: 4

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Cases/families6WorldwideValidated
Point prevalence<1 / 1 000 000WorldwideValidated

Identifiers

Disease identifiers

FieldValue
Canonical namecold-induced sweating syndrome
Mondo IDMONDO:0015526
OMIM272430
Orphanet157820
DOIDDOID:0060294
ICD-111884908195
SNOMED CT702363009
UMLSC1832409
MedGen321950
GARD0016983
Is cancer (heuristic)no

Also known as: CISS

Data availability: 4 ClinVar variants · 3 GenCC gene-disease records.

Disease family

An umbrella term covering 3 Mondo subtypes.

Classification path: disease › human disease › disease by body system or component › nervous system disorderperipheral nervous system disorderperipheral neuropathysensory peripheral neuropathyhereditary sensory and autonomic neuropathycold-induced sweating syndrome - hyperthermia spectrumcold-induced sweating syndrome

Subtypes (3): Cold-induced sweating syndrome 1, cold-induced sweating syndrome 2, PERCHING syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

ClinVar germline variants

4 retrieved; paginated sample, class counts are floors:

3 likely pathogenic, 1 pathogenic

ClinVarVariant (HGVS)GeneClassificationReview
1322162NM_004750.5(CRLF1):c.31_53del (p.Gln11fs)CRLF1Pathogeniccriteria provided, multiple submitters, no conflicts
1698520NM_004750.5(CRLF1):c.1A>G (p.Met1Val)CRLF1Likely pathogeniccriteria provided, single submitter
1705180NM_004750.5(CRLF1):c.4_10del (p.Pro2fs)CRLF1Likely pathogeniccriteria provided, single submitter
3063901NM_004750.5(CRLF1):c.-131_21del (p.Met1fs)CRLF1Likely pathogeniccriteria provided, single submitter

Genes & proteins

Mendelian disease overlap and somatic drivers

GenCC: 19 · Orphanet: 10 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0

GenCC gene–disease validity (cohort genes)

the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.

GeneClassificationInheritanceDiseaseRecords
CRLF1DefinitiveAutosomal recessiveCold-induced sweating syndrome 16
CLCF1StrongAutosomal recessivecold-induced sweating syndrome 23
KLHL7SupportiveAutosomal recessivecold-induced sweating syndrome10

Orphanet rare-disease linkage (cohort genes)

GeneOrphanet IDRare disease
CRLF1Orphanet:1545Crisponi syndrome
CRLF1Orphanet:157820Cold-induced sweating syndrome
CRLF1Orphanet:930Idiopathic achalasia
KLHL7Orphanet:157820Cold-induced sweating syndrome
KLHL7Orphanet:603684KLHL7-related Bohring-Opitz-like and Crisponi/Cold-induced sweating-like overlap syndrome
KLHL7Orphanet:603689KLHL7-related Bohring-Opitz-like syndrome
KLHL7Orphanet:603694KLHL7-related Crisponi/cold-induced sweating-like syndrome
KLHL7Orphanet:791Retinitis pigmentosa
CLCF1Orphanet:1545Crisponi syndrome
CLCF1Orphanet:157820Cold-induced sweating syndrome

Cohort genes → proteins

3 cohort genes, 3 distinct canonical proteins.

Evidence partition

SubsetGenes
multi_evidence3

Cohort genes (full)

SymbolHGNCEnsemblUniProtNameEvidence
CRLF1HGNC:2364ENSG00000006016O75462Cytokine receptor-like factor 1gencc,clinvar
KLHL7HGNC:15646ENSG00000122550Q8IXQ5Kelch-like protein 7gencc
CLCF1HGNC:17412ENSG00000175505Q9UBD9Cardiotrophin-like cytokine factor 1gencc

Cohort function summary

Lead sentence per gene, UniProt-curated.

SymbolProtein nameFunction (lead sentence)
CRLF1Cytokine receptor-like factor 1In complex with CLCF1, forms a heterodimeric neurotropic cytokine that plays a crucial role during neuronal development.
KLHL7Kelch-like protein 7Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex.
CLCF1Cardiotrophin-like cytokine factor 1In complex with CRLF1, forms a heterodimeric neurotropic cytokine that plays a crucial role during neuronal development.

Protein-family classification

Druggable: 1 · Difficult: 0 · Unknown: 2 · Druggable fraction: 0.33

Family distribution

Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.

FamilyGenesFoldFDR
Antibody/Immunoglobulin19.7×0.199
Other/Unknown21.2×0.587

Per-gene assignment

SymbolFamilyDruggable?ECInterPro (top 3)
CRLF1Antibody/Immunoglobulinyes1.1.1.105FN3_dom, Ig-like_fold, Growth/epo_recpt_lig-bind
KLHL7Other/UnknownnoBTB/POZ_dom, Kelch_1, SKP1/BTB/POZ_sf
CLCF1Other/Unknownno4_helix_cytokine-like_core, PRF/CT

Expression context

Cohort genes with no expression data: 0.

3 cohort genes are a single-cell marker in ≥1 SCXA experiment.

Breadth distribution (Bgee present_calls)

BucketGenes
narrow (1-5 tissues)0
moderate (6-20)0
broad (>20)3
unknown0

Top tissues across cohort

TissueCohort genes
popliteal artery1
right coronary artery1
tibial artery1
heart right ventricle1
oocyte1
secondary oocyte1
left uterine tube1
male germ line stem cell (sensu Vertebrata) in testis1
metanephros cortex1

Per-gene tissue summary (top 30)

SymbolBgee breadthFANTOM5 breadthSCXATop tissues
CRLF1227ubiquitousmarkerright coronary artery, popliteal artery, tibial artery
KLHL7274ubiquitousmarkeroocyte, secondary oocyte, heart right ventricle
CLCF1187ubiquitousmarkerleft uterine tube, metanephros cortex, male germ line stem cell (sensu Vertebrata) in testis

Protein interactions among cohort

Intra-cohort edges: 2.

Hub genes (top 10 by interactor count)

SymbolInteractor count
KLHL71,123
CRLF1589
CLCF1491

Intra-cohort edges

ABSources
CLCF1CRLF1intact, string_interaction
CRLF1KLHL7string_interaction

Structural data

PDB: 3 · AlphaFold-only: 0 · No structure: 0

Cohort genes with PDB structures (top 30)

SymbolUniProtPDB entries
CLCF1Q9UBD92
CRLF1O754621
KLHL7Q8IXQ51

Function

Pathway analysis

Distinct Reactome pathways touched by cohort: 2. Enrichment computed across 3 evidence-associated genes (2 with Reactome annotation).

Pathways by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 2 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

PathwayCohort genesFoldFDRSample cohort genes
IL-6-type cytokine receptor ligand interactions2634.4×5e-06CRLF1, CLCF1
Interleukin-27 signaling1519.1×0.002CRLF1

GO biological processes by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 3 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

GO termCohort genesFoldFDRSample cohort genes
cell surface receptor signaling pathway via STAT2374.5×1e-04CRLF1, CLCF1
cytokine-mediated signaling pathway287.1×0.001CRLF1, CLCF1
negative regulation of neuron apoptotic process273.9×0.001CRLF1, CLCF1
positive regulation of isotype switching to IgE isotypes11404.3×0.003CLCF1
negative regulation of motor neuron apoptotic process1510.7×0.005CRLF1
positive regulation of astrocyte differentiation1468.1×0.005CLCF1
positive regulation of cell population proliferation222.4×0.006CRLF1, CLCF1
positive regulation of immunoglobulin production1160.5×0.011CLCF1
ureteric bud development1151.8×0.011CRLF1
positive regulation of B cell proliferation1114.6×0.013CLCF1
cell surface receptor signaling pathway via JAK-STAT196.8×0.014CLCF1
B cell differentiation173.0×0.017CLCF1
cell surface receptor signaling pathway121.4×0.053CLCF1
proteasome-mediated ubiquitin-dependent protein catabolic process117.4×0.060KLHL7
protein ubiquitination113.8×0.071KLHL7

Therapeutics

Drug target analysis

Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 3

Druggability breadth: 1 of 3 evidence-associated genes (33%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).

Top cohort targets by molecule count

SymbolMoleculesMax phase
CRLF100
KLHL700
CLCF100

Bioactivity and enzyme data

Enzyme cohort genes (≥1 EC): 1.

Cohort genes with ChEMBL bioactivity (full, sorted by assay count)

SymbolAssaysType breakdown
KLHL71Binding:1

Cohort enzymes (BRENDA EC)

SymbolEC numbersNames
CRLF11.1.1.105all-trans-retinol dehydrogenase (NAD+)

Pharmacogenomics

Cohort genes with a PharmGKB record: 3; with CPIC/DPWG dosing guidelines: 0.

No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).

Chemical tractability of cohort targets

0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.

Druggability pyramid

Cohort genes binned by druggability tier (high → low):

TierDefinitionGenesSymbols
AApproved (phase 4 drug)0
BPhased (≥1) drug, not yet approved0
CDruggable family + PDB, no drug1CRLF1
DDruggable family + AlphaFold only, no drug0
EDifficult family or no structure, no drug2KLHL7, CLCF1

Undrugged target profiles

3 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).

SymbolChEMBL assaysDrugged partners (top 3)
CRLF10
KLHL71
CLCF10

Clinical trials & evidence

Clinical trials

Clinical trials: 0.